Reply to "A better interpretation of data regarding the opioid switching to methadone"

Reply to "A better interpretation of data regarding the opioid switching to methadone"

In our article ?Methadone switching for refractory cancer pain' (BMC palliative care, 2022) we explore the efficacy, safety and economics of methadone in treatment of patients with refractory cancer pain in China. Professor Mercadante provided a better interpretation of data regarding the opioi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC palliative care 2023-06, Vol.22 (1), p.66-66, Article 66
Hauptverfasser: Ding, Haiying, Song, Yu, Xin, Wenxiu, Sun, Jiao, Zhong, Like, Zhou, Qinfei, He, Chaoneng, Gong, Liyan, Fang, Luo
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Cancer pain
Clinical medicine
Cytochrome
Drug dosages
Enzymes
Matters Arising
Methadone
Methods
Morphine
Narcotics
Opioid switching or rotation
Pain
Palliative care
Pharmacodynamics
Pharmacokinetics
Population
White people
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In our article ?Methadone switching for refractory cancer pain' (BMC palliative care, 2022) we explore the efficacy, safety and economics of methadone in treatment of patients with refractory cancer pain in China. Professor Mercadante provided a better interpretation of data regarding the opioid switching to methadone in the Matters Arising. In this article, we answered the questions in Mercadante et al.'s comments one by one.
ISSN:1472-684X
1472-684X
DOI:10.1186/s12904-023-01162-z